Establishment Labs Holdings Inc. (ESTA) Prices 3.72M Share IPO at $18/Sh

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the pricing of its initial public offering of 3,715,277 common shares at a public offering price of $18.00 per share. All of the common shares are being offered by Establishment Labs. In addition, Establishment Labs has granted the underwriters a 30-day option to purchase up to 557,291 additional common shares at the initial public offering price, less underwriting discounts and commissions.

The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Establishment Labs, are expected to be approximately $66.9 million, excluding any proceeds from the exercise of the underwriters’ option to purchase additional common shares. Establishment Labs’ common shares are expected to begin trading on the Nasdaq Capital Market under the ticker symbol “ESTA” on July 19, 2018. The offering is expected to close on July 23, 2018, subject to customary closing conditions.

Jefferies LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering. BTIG, LLC is acting as lead manager for the offering.

You May Also Be Interested In

• Entrata (ENT) files for proposed IPO
• Easy Aerial Completes $20 Million Series B Funding Round to Expand Global Defense Footprint
• Solidion Technology adds three independent directors to its board